Histone deacetylase inhibitors: a promising partner for MEK inhibitors in uveal melanoma?

被引：2
|
作者：
Faiao-Flores, Fernanda [1 ]
Smalley, Keiran S. M. [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, 12902 Magnolia Dr, Tampa, FL USA
来源：
MELANOMA MANAGEMENT | 2019年 / 6卷 / 04期
关键词：
clinical trials; endothelin; HDAC inhibition; IGF1R; MEK inhibition; plasticity; ROR1; signaling; uveal melanoma; BAP1; GROWTH; CELLS;
D O I：
10.2217/mmt-2019-0017
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页数：5
相关论文
共 50 条
  • [1] The Role of Histone Deacetylase Inhibitors in Uveal Melanoma: Current Evidence
    Moschos, Marilita M.
    Dettoraki, Maria
    Androudi, Sofia
    Kalogeropoulos, Dimitrios
    Lavaris, Anastasios
    Garmpis, Nikolaos
    Damaskos, Christos
    Garmpi, Anna
    Tsatsos, Michael
    [J]. ANTICANCER RESEARCH, 2018, 38 (07) : 3817 - 3824
  • [2] Histone Deacetylase Inhibitors Induce Growth Arrest and Differentiation in Uveal Melanoma
    Landreville, Solange
    Agapova, Olga A.
    Matatall, Katie A.
    Kneass, Zachary T.
    Onken, Michael D.
    Lee, Ryan S.
    Bowcock, Anne M.
    Harbour, J. William
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (02) : 408 - 416
  • [3] Histone deacetylase inhibitors and malignant melanoma
    Boyle, GM
    Martyn, AC
    Parsons, PG
    [J]. PIGMENT CELL RESEARCH, 2005, 18 (03): : 160 - 166
  • [4] Evaluation of the Therapeutic Potential of Histone Deacetylase 6 Inhibitors for Primary and Metastatic Uveal Melanoma
    Sundaramurthi, Husvinee
    Giricz, Zoltan
    Kennedy, Breandan N.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (16)
  • [5] Selective histone deacetylase 6 inhibitors as a potential therapeutic option for metastatic uveal melanoma
    Sundaramurthi, Husvinee
    Mulero, Sandra Garcia
    Piulats, Josep
    Watson, William
    Tobin, Desmond
    Kennedy, Breandan
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2021, 178 (24) : 4982 - 4983
  • [6] Histone Deacetylase (HDAC) Inhibitors: A Promising Weapon to Tackle Therapy Resistance in Melanoma
    Palamaris, Kostas
    Moutafi, Myrto
    Gakiopoulou, Hariklia
    Theocharis, Stamatios
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
  • [7] Strategies in Developing Promising Histone Deacetylase Inhibitors
    Zhang, Lei
    Fang, Hao
    Xu, Wenfang
    [J]. MEDICINAL RESEARCH REVIEWS, 2010, 30 (04) : 585 - 602
  • [8] Evaluation of Anti-Cancer Properties of Selective Histone Deacetylase 6 Inhibitors in Uveal Melanoma
    Sundaramurthi, Husvinee
    Mulero, Sandra
    Buckley, Melody
    Piulats, Josep
    Kennedy, Breandan
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [9] Identification of histone deacetylase inhibitors with (arylidene)aminoxy scaffold active in uveal melanoma cell lines
    Nencetti, Susanna
    Cuffaro, Doretta
    Nuti, Elisa
    Ciccone, Lidia
    Rossello, Armando
    Fabbi, Marina
    Ballante, Flavio
    Ortore, Gabriella
    Carbotti, Grazia
    Campelli, Francesco
    Banti, Irene
    Gangemi, Rosaria
    Marshall, Garland R.
    Orlandini, Elisabetta
    [J]. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2021, 36 (01) : 34 - 47
  • [10] Monosomy 3 Is Linked to Resistance to MEK Inhibitors in Uveal Melanoma
    Mergener, Svenja
    Siveke, Jens T.
    Pena-Llopis, Samuel
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (13)
12345